← Back to Search

Fasting for Low Blood Sugar

N/A
Waitlist Available
Research Sponsored by University of Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during intervention
Awards & highlights

Study Summary

This trial will test whether changes in liver glycogen content affects hypoglycemic responses in people without type 1 diabetes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and during intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Epinephrine
Glucagon
Glucose infusion rate
Secondary outcome measures
Glucose
Peripheral glucose uptake

Side effects data

From 2015 Phase 4 trial • 15 Patients • NCT01380366
7%
Hospitalization for Escherichia coli Infection
7%
Hospitalization for Gram-positive Cocci
7%
Hospitalization for positive line infection
7%
Pancreatitis
7%
Hospitalization for abdominal pain (pre-treatment)
7%
Hospitalization for Flu like Symptoms
100%
80%
60%
40%
20%
0%
Study treatment Arm
Patients Consented to be Given rHGH

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: FastingExperimental Treatment1 Intervention
Subjects will remain fasted prior to insulin-induced hypoglycemia.
Group II: FeedingActive Control1 Intervention
Subjects will eat a normal breakfast and lunch prior to insulin-induced hypoglycemia.

Find a Location

Who is running the clinical trial?

University of CincinnatiLead Sponsor
427 Previous Clinical Trials
634,350 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025